Abstract 2317: Preclinical model of Ribociclib resistance in HR-positive breast cancer

Authors: Jennifer Carlson Aske, Pradip De, Nandini Dey

Published: 2022-06-15

DOI: 10.1158/1538-7445.am2022-2317

Source: Full article


Abstract

Abstract